BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4 There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01 (also known as Mosquirix) is the most advanced malaria vaccine and was shown to have modest efficacy ...against clinical malaria in phase III trials in 5- to 17-month-old infants. Following pilot implementation trials, the World Health Organisation has recommended it for use in Africa in young children who are most at risk of infection with P. falciparum, the deadliest of the human malaria parasites. more

Clinical Pharmacology: Advances and Applications, 2025:17 29–47

Tropical Medicine and Health (2023) 51:29